首页> 外文OA文献 >Clinical Usefulness of Streptococcus pneumoniae Urinary Antigen in Patients Hospitalized with Non-Nosocomial Pneumonia
【2h】

Clinical Usefulness of Streptococcus pneumoniae Urinary Antigen in Patients Hospitalized with Non-Nosocomial Pneumonia

机译:非医院内肺炎住院患者肺炎链球菌尿抗原的临床价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction : Community acquired pneumonia (CAP) is a major cause of hospital admissions and mortality in developed countries. Nevertheless, in about half of the cases a microbial etiology can`t be determined. The need to improve the diagnostic tools of this disease has led to the development of new techniques, such as Streptococcus pneumoniae urinary antigen. Objectives : To analyse the usefulness of the urinary antigen in determining the etiologic diagnosis of pneumonias and its influence in the antibiotherapy modification. Methods : Retrospective analysis of hospitalized patients in 2010 with CAP (n=226) and healthcare associated pneumonia (HCAP) [n=64] diagnosis whose urinary pneumococcal antigen has been analyzed. Results: Median age was significantly greater in HCAP. HCAP patients had more co-morbidities and higher severity scores. Twenty-one patients in the CAP group and 4 patients in the HCAP group had positive pneumococcal antigen. The sensibility of urinary antigen in determining pneumococcal pneumonias was 36% and the specificity 89%. Almost one quarter of the 25 patients with positive urinary antigen had appropriate reductions in antimicrobial spectra, which was not statistically significant when compared with the group with negative urinary antigen. There was a significant relation between a positive urinary antigen and pneumonia severity. Conclusions: Considering its high specificity, the urinary antigen is useful to confirm the presence of pneumococcal pneumonia.Potentially urinary antigen can help to avoid unnecessary treatments in hospitalized patients with CAP.
机译:简介:社区获得性肺炎(CAP)是发达国家住院和死亡的主要原因。然而,在大约一半的情况下,无法确定微生物病因。需要改进这种疾病的诊断工具导致了新技术的发展,例如肺炎链球菌尿抗原。目的:分析尿抗原在确定肺炎的病因学诊断中的作用及其对抗生物疗法的影响。方法:回顾性分析2010年住院患者的CAP(n = 226)和医疗保健相关性肺炎(HCAP)[n = 64]的诊断,分析其尿中肺炎球菌抗原。结果:HCAP患者的中位年龄明显更高。 HCAP患者的合并症更多,严重程度评分更高。 CAP组中的21例患者和HCAP组中的4例患者的肺炎球菌抗原呈阳性。尿抗原测定肺炎球菌性肺炎的敏感性为36%,特异性为89%。 25例尿液抗原阳性患者中有近四分之一的抗菌谱适当降低,与尿液抗原阴性的患者相比无统计学意义。尿抗原阳性与肺炎的严重程度之间存在显着的关系。结论:鉴于尿抗原的高特异性,可用于确认肺炎球菌性肺炎的存在,潜在的尿抗原可帮助避免住院的CAP患者不必要的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号